Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs021220004Completed
Open-label, single-arm trial of triamcinolone acetonide in lower gastrointestinal tract stenosis. Primary endpoint: Primary safety endpoint. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs021220004.